Circus Aktie 131725919 / DE000A2YN355
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
27.10.2025 07:30:03
|
EQS-News: Circus Establishes Operational Presence in the Ukraine War
|
EQS-News: Circus SE
/ Key word(s): Product Launch/Expansion
Circus Establishes Operational Presence in the Ukraine War
The newly formed local partnerships will bring extensive knowledge in defense technology, systems integration, and operational support. The Kyiv-based team will serve to establish a regional hub for deployment, maintenance, sales support, and operational training of the CA-M AI robotic systems across Ukraine. “Establishing a local presence in Ukraine underscores our strong commitment to operational excellence and on-ground readiness,” said Nikolas Bullwinkel, Founder and CEO of Circus SE. “Ukraine represents a key operational and growth focus for us, with a wide range of potential applications across the region. With our autonomous, AI-driven supply systems, we provide reliable infrastructure even under the most challenging conditions – from remote bases to mobile operation centers.” The CA-M system is designed for rapid tactical deployment and enables autonomous supply operations with minimal human involvement. Leveraging Circus’ proprietary embodied AI technology and modular system architecture, the CA-M delivers freshly prepared, nutritionally balanced meals even under extreme conditions – independent of conventional supply chains and with maximum reliability in critical regions. The first CA-M deployments in the region are expected to begin in the coming months, in collaboration with regional expansion partners. These initial operations will lay the foundation for a broader rollout strategy, supporting a wide range of national clients with scalable, autonomous nutrition infrastructure. With this expansion, Circus strengthens its European operations network and reaffirms its mission to redefine supply through robotics and AI, providing governments, defense organizations, and humanitarian actors with next-generation autonomous systems for resilient field nutrition. About Circus SE Circus SE (XETRA: CA1) is a global AI and robotics company developing autonomous systems for food supply in both civilian and defense sectors. Its flagship robot, the patented CA-1, is the world’s first fully autonomous food production robot, now in serial production. Powered by proprietary embodied AI, Circus delivers industrial-scale, high-reliability meal output with minimal human input. Headquartered in Munich, the company is building the global infrastructure for autonomous food supply – on a mission to fuel humanity. Contact Circus SE
27.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Circus SE |
| St. Martin-Strasse 112 | |
| 81669 München | |
| Germany | |
| E-mail: | ir@circus-group.com |
| Internet: | https://www.circus-group.com/for-investors |
| ISIN: | DE000A2YN355 |
| WKN: | A2YN35 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich (m:access), Tradegate Exchange |
| EQS News ID: | 2218716 |
| End of News | EQS News Service |
|
|
2218716 27.10.2025 CET/CEST
Nachrichten zu Circus SE Inhaber-Akt
Analysen zu Circus SE Inhaber-Akt
Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall
Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.
Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.
🎯 Themen im Interview mit Etienne Jornod (OM Pharma)
– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Nach US-Zinsentscheid: US-Börsen schliessen uneins -- SMI und DAX letztlich schwächer -- Asiens Börsen schlussendlich im Plus - Nikkei mit AllzeithochDer heimische Aktienmarkt machte zur Wochenmitte Verluste. Der deutsche Aktienmarkt tendierte am Mittwoch abwärts. Die US-Börsen fanden keine gemeinsame Richtung. Die wichtigsten Aktienmärkte in Fernost verbuchten teilweise große Gewinne.


